Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy.
Autorzy:
Houédé N; Institut de Cancérologie du Gard - CHU Caremeau, 30029, Nîmes, Cedex 9, France. . Locker G; Department of Internal Medicine I, Währinger Gürtel.18-20, 1090, Vienne, Austria. Lucas C; Institut de Recherche Pierre Fabre, 45 place Abel Gance, 92100, Boulogne-Billancourt, France. Parra HS; Oncologia Medica, P.O Gaspare Rodolico, Via Santa Sofia 78, 95123, Catania, Italy. Basso U; Istituto Oncologico Veneto IOV-IRCCS, Dipartmento di Oncologia Clinica e Sperimentale, Oncologia Medica 1, via Gattamelata 64, 35128, Padova, Italy. Spaeth D; Centre d'Oncologie de Gentilly, 2 rue Marie Marvingt, 54100, Nancy, France. Tambaro R; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Via Mariano Semmola, 80131, Napoli, Italy. Basterretxea L; Hospital Universitario Donostia, Begiristain Doktorea Pasealekua 117-20080, Donostia, Gipuzkoa - San Sebastián, Spain. Morelli F; Fondazione Casa Sollievo della Sofferenza Oncologia, Viale Cappuccini 1, San Giovanni Rotondo, Foggia, Italy. Theodore C; Hopital Foch, 40 rue Worth, 92150, Suresnes, France. Lusuardi L; Reparto di Urologia - Ospedale di Bressanone, Via Dante 51, 39042, Bressanone, Italy. Lainez N; Hospital de Navarra - Virgen del Camino, Oncología Médica, Calle de Irunlarrea, 4 planta baja, 31008, Pamplona, Spain. Guillot A; Institut de cancérologie de la Loire, 108 bis avenue Albert Raimond, 42271, Saint Priest en Jarez, Cedex, France. Tonini G; Policlinico Universitario Campus Bio-medico Oncologia Medica, Via Alvaro del Portillo 200, 00128, Roma, Italy. Bielle J; Institut de Recherche Pierre Fabre, 45 place Abel Gance, 92100, Boulogne-Billancourt, France. DelMuroXG; ICO L'Hospitalet, Avinguda Granvia, 199-203, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2016 Sep 23; Vol. 16 (1), pp. 752. Date of Electronic Publication: 2016 Sep 23.
Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study.
Autorzy:
Maurel J; Department of Medical Oncology, Hospital Clinic, CIBERehd, Translational Genomics and Targeted Therapeutics in Solid Tumors (IDIBAPS), Barcelona, Spain. López-Pousa A; Department of Medical Oncology, Hospital Universitario Sant Pau, Barcelona, Spain. Calabuig S; Molecular Oncology Laboratory, Fundación de Investigación del Hospital General Universitario de Valencia, Valencia, Spain. Bagué S; Pathology Department, Hospital Universitario Sant Pau, Barcelona, Spain. DelMuroXG; Department of Medical Oncology, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain. Sanjuan X; Pathology Department, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain. Rubió-Casadevall J; Department of Medical Oncology, Institut Català d'Oncologia de Girona, Girona, Spain. Cuatrecasas M; Pathology Department, Hospital Clínic, CIBERehd, IDIBAPS, Barcelona, Spain. Martinez-Trufero J; Department of Medical Oncology, Hospital Universitario Miguel Servet, Saragossa, Spain. Horndler C; Pathology Department, Hospital Universitario Miguel Servet, Saragossa, Spain. Fra J; Department of Medical Oncology, Hospital Central de Asturias, Oviedo, Spain. Valverde C; Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. Redondo A; Hospital Universitario La Paz, Madrid, Spain. Poveda A; Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain. Sevilla I; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria y Regional de Málaga, Málaga, Spain. Lainez N; Department of Medical Oncology, Hospital de Navarra, Pamplona, Spain. Rubini M; Department of Experimental and Diagnostic Medicine, Department of Epidemiology, University of Ferrara (UNIFE), Emilia-Romagna, Italy. García-Albéniz X; Harvard T.H. Chan School of Public Health, Boston, MA USA. Martín-Broto J; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain. de Alava E; Pathology Department, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
Pokaż więcej
Źródło:
Clinical sarcoma research [Clin Sarcoma Res] 2016 Jun 29; Vol. 6, pp. 10. Date of Electronic Publication: 2016 Jun 29 (Print Publication: 2016).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
